Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;7(1):40-5.
doi: 10.3400/avd.oa.13-00092. Epub 2014 Feb 28.

Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital

Affiliations

Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital

Surajit Awsakulsutthi et al. Ann Vasc Dis. 2014.

Abstract

Background: Chronic diabetic foot ulcer has a high rate of healing failure. Beraprost sodium, oral form of prostaglandin I2 analogue, maybe used for increasing wound healing.

Objective: To compare the healing rate of chronic diabetic foot ulcer between Beraprost sodium and control groups.

Design: A single blind randomized trial.

Materials and methods: Fifty non-healed chronic diabetic foot ulcer patients were randomized to be the study and control groups. Beraprost sodium was prescribed in the study group according to protocol.

Results: At 6th week follow up, median wound healing rate in the study group was significantly higher than in the control group with the rate of 88.1% and 33.3%, respectively. Complete wound healing in the study group was also significantly higher than in the control group (48%:8%). In the study group, 9 patients (37.5%) could be administered with recommended dose. Side effects were headache in 14 patients (58.3%) and palpitation in one patient (4.2%). One patient was discontinued for severe headache.

Conclusions: The use of Beraprost sodium in chronic diabetic foot ulcer patients significantly increases the wound healing rate. Headache was the common side effect.

Keywords: Beraprost sodium; PG I2 analogue; chronic diabetic foot ulcer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Wound healing after used beraprost sodium at 0, 2nd, 6th week.

Similar articles

Cited by

References

    1. Aekplakorn W, Stolk RP, Neal B, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003; 26: 2758-63 - PubMed
    1. Krittiyawong S, Ngarmukos C, Benjasuratwong Y, et al. Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics. J Med Assoc Thai 2006; 89Suppl 1: S43-8 - PubMed
    1. Nishibe T. Beraprost: optimising drug therapy for PAD with complications. Ann Vasc Dis 2010; 3: 97-8
    1. Aso Y, Tayama K, Takanashi K, et al. Changes in skin blood flow in type 2 diabetes induced by prostacyclin: association with ankle brachial index and plasma thrombomodulin levels. Metab Clin Exp 2001; 50: 568-72 - PubMed
    1. Toyota T, Oikawa S, Beraprost Sodium Study Group Effects of beraprost sodium (Dorner) in patients with diabetes mellitus complicated by chronic arterial obstruction. Angiology 2002; 53: 7-13 - PubMed

LinkOut - more resources